On September 6th, edan instruments, inc. stated on the investor interactive platform that the company's molecular diagnostic platform has the ability to detect monkeypox virus, but it has not yet obtained registration and certification for this product domestically and internationally. The company will continue to monitor the market demand for monkeypox virus and changes in regulatory policies. If there is an increase in clinical demand in the future, and there is a feasible fast-track emergency approval registration channel, the company will timely proceed with the registration and certification of relevant products.